Showing results (91-100 of 105) with videos related to
Sort By:
Pageof 11
Oncotarget|June 23, 2016
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancerTheodoros Karantanos, Styliani Karanika, Jianxiang Wang, et al.Cell Reports|February 24, 2017
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Theodoros Karantanos, Likun Li, et al.Diabetes|April 24, 2024
Inhibitory Regulation of FOXO1 in PPARδ Expression Drives Mitochondrial Dysfunction and Insulin ResistanceSoyoung Park, Hye-Na Cha, Min-Gyeong Shin, et al.Clinical Endocrinology|August 2, 2026
Effectiveness of Recombinant Human Growth Hormone Therapy in Small-for-Gestational-Age Children With Short Stature: A Stratified Analysis Based on Genetic Variant StatusSanghee Park, Yena Lee, Hwal Rim Jeong, et al.Nature Communications|August 29, 2020
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody Vykoukal, Johannes F Fahrmann, Justin R Gregg, et al.Plos One|September 28, 2019
An international survey of perceptions of the 2014 FIFA World Cup: National levels of corruption as a context for perceptions of institutional corruptionJohn B Nezlek, David B Newman, Astrid Schütz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Likun Li, Guang Yang, et al.Journal for Immunotherapy of Cancer|May 17, 2022
Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustionByong-Sop Song, Ji Sun Moon, Jingwen Tian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.Pageof 11